Last reviewed · How we verify
monoclonal antibody 11D10 anti-idiotype
monoclonal antibody 11D10 anti-idiotype is a Biologic drug developed by Alliance for Clinical Trials in Oncology. It is currently in Phase 2 development. Also known as: TriAb.
At a glance
| Generic name | monoclonal antibody 11D10 anti-idiotype |
|---|---|
| Also known as | TriAb |
| Sponsor | Alliance for Clinical Trials in Oncology |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver (PHASE2)
- Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery (PHASE2)
- S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- monoclonal antibody 11D10 anti-idiotype CI brief — competitive landscape report
- monoclonal antibody 11D10 anti-idiotype updates RSS · CI watch RSS
- Alliance for Clinical Trials in Oncology portfolio CI
Frequently asked questions about monoclonal antibody 11D10 anti-idiotype
What is monoclonal antibody 11D10 anti-idiotype?
monoclonal antibody 11D10 anti-idiotype is a Biologic drug developed by Alliance for Clinical Trials in Oncology.
Who makes monoclonal antibody 11D10 anti-idiotype?
monoclonal antibody 11D10 anti-idiotype is developed by Alliance for Clinical Trials in Oncology (see full Alliance for Clinical Trials in Oncology pipeline at /company/alliance-for-clinical-trials-in-oncology).
Is monoclonal antibody 11D10 anti-idiotype also known as anything else?
monoclonal antibody 11D10 anti-idiotype is also known as TriAb.
What development phase is monoclonal antibody 11D10 anti-idiotype in?
monoclonal antibody 11D10 anti-idiotype is in Phase 2.
Related
- Manufacturer: Alliance for Clinical Trials in Oncology — full pipeline
- Also known as: TriAb
- Compare: monoclonal antibody 11D10 anti-idiotype vs similar drugs
- Pricing: monoclonal antibody 11D10 anti-idiotype cost, discount & access